HIV / AIDS in the News

Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients - Medical Xpress

 

I’m Here to Advocate & Support the HIV Community - POZ

 

Trump admin planning to consolidate HIV programs, slashing 'overhead' and DEI: official - Fox News

 

Impact of US funding cuts on HIV programmes in Uzbekistan - UNAIDS

 

'Work to do' to tackle HIV stigma, says Berkshire charity - BBC.com

 

HIV Is on the Brink of Defeat, but Trump’s Pending Funding Cuts Could Bring It Back - Gizmodo

 

Impact of US funding cuts on HIV programmes in Latin America and the Caribbean - UNAIDS

 

Impact of US funding cuts on HIV programmes in Vietnam - UNAIDS

 

BMO reiterates Gilead stock with $115 target amid HIV funding concerns - Investing.com

 

Citi maintains Gilead stock Buy rating, $125 target amid HIV funding fears - Investing.com

 

Trump admin moves to end federal HIV prevention programs. ‘Catastrophic’ consequences, experts say - Advocate.com

 

White House announces possible cuts to CDC's HIV prevention office - 11Alive.com WXIA

 

Trump may eliminate CDC’s HIV prevention division despite risk of public health disaster - LGBTQ Nation

 

Impact of US funding cuts on the global AIDS response – 17 March 2025 update - UNAIDS

 

HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable - The Wall Street Journal

 

Gilead Sciences Stock Slips on Possible HIV Funding Cut - Schaeffers Research

 

Study shows significant progress in HIV treatment initiation in the Asia-Pacific region - Medical Xpress

 

No meds, no doctor: How Trump's HIV cuts hit trans Namibians - Context

 

Electronic cigarettes may pose lower cardiovascular risks for people with HIV - News-Medical.Net

 

The Trump Administration Wants to Cut Funding for HIV Prevention. Why Gilead Stock Is Falling. - Barron's

 

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention - Markets Insider

 

Impact of US funding cuts on HIV programmes in Uganda - UNAIDS

 

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention - AOL

 

Pharmalittle: We're reading about possible HIV prevention cuts, FDA warning an Africa drugmaker, and more - STAT

 

Trump Eyes Steep Cuts to CDC HIV Prevention Program - BioSpace

 

Trump’s policies threaten his 2019 vow to end HIV, experts say - Roll Call

 

Protesters gather outside Atlanta CDC; HIV division elimination rumors - FOX 5 Atlanta

 

Gilead slides as Trump administration puts HIV prevention funds under review - TradingView

 

From violence to funding cuts, Asia Pacific women living with HIV face old and new challenges - UNAIDS

 

Semaglutide May Help Improve Cognition in Adults With HIV - Medscape